Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRINITY: Fixed Triple Therapy (Trimbow) vs Tiotropium in Severe COPD
NCT01911364Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jan 2014
- Primary completion
- Mar 2016
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of beclometasone dipropionate/formoterol fumarate/glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started Jan 2014; status: completed.
02
Drugs
beclometasone dipropionate/formoterol fumarate/glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01911364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01911364.